In the Boardroom - Merck KGaA

Filter

Current filters:

Merck KGaA

Popular Filters

74 to 98 of 186 results

Clarity appoints Alan Taylor as new Executive Chairman to the board

Clarity appoints Alan Taylor as new Executive Chairman to the board

19-12-2013

Sydney-based companion diagnostic and personalized medicine company Clarity has appointed Alan Taylor…

AustraliaBoardroomClarityPharmaceutical

Pfizer names Albert Bourla as group president as Amy Schulman steps down

Pfizer names Albert Bourla as group president as Amy Schulman steps down

18-12-2013

Changes in Pfizer’s (NYSE: PFE) executive leadership have been announced this week.

BoardroomPfizerPharmaceuticalUSA

Lophius Biosciences Appoints Dr Robert Phelps as director of business operations

16-12-2013

German biotechnology company Lophius Biosciences GmbH has announced that Dr Robert Phelps has joined…

Antibiotics and Infectious diseasesBiotechnologyBoardroomEuropeImmunologicals

Lundbeck appoints Jacob Tolstrup as senior vice president for Business Development

Lundbeck appoints Jacob Tolstrup as senior vice president for Business Development

16-12-2013

Danish pharmaceutical company H. Lundbeck A/S has appointed Jacob Tolstrup as head of the HR department…

BoardroomDenmarkEuropeH. LundbeckLundbeckNeurologicalPharmaceutical

Merck’s Allergopharma to invest 40 million euros in production facility

Merck’s Allergopharma to invest 40 million euros in production facility

12-12-2013

Germany’s Merck KGaA has broken ground on a new production facility for its Allergopharma unit in Reinbek…

AllergopharmaFinancialImmunologicalsMerck KGaAPharmaceuticalProduction

Teva vice chairman Moshe Many to leave post for 'personal reasons'

Teva vice chairman Moshe Many to leave post for 'personal reasons'

11-12-2013

Israel’s Teva Pharmaceutical Industries announced yesterday that the vice chairman of its board of…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Roche board of directors to be decided at AGM in March

Roche board of directors to be decided at AGM in March

10-12-2013

Swiss drug major Roche (ROG: SIX) has issued a list of members of the Board of Directors to be elected…

BoardroomNorthern EuropePharmaceuticalRoche

Nuevolution appoints Ton Berkien as chief business officer

Nuevolution appoints Ton Berkien as chief business officer

09-12-2013

Denmark-based small molecule lead discovery company Nuevolution A/S has appointed Ton Berkien as Chief…

BoardroomDenmarkEuropeNuevolutionPharmaceutical

ThromboGenics founder Désiré Collen to retire

ThromboGenics founder Désiré Collen to retire

09-12-2013

Belgium-based biopharma firm ThromboGenics (Euronext Brussels: THR: BR) has announced that Désiré Collen…

BelgiumBoardroomEuropePharmaceuticalThromboGenics

Novasep announces Nadege Laborde as new president of its industrial biotech business unit

Novasep announces Nadege Laborde as new president of its industrial biotech business unit

06-12-2013

The France-based biotechnology company Novasep has announced Nadege Laborde as the new president of its…

BiotechnologyBoardroomEuropeNovasep

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

03-12-2013

The UK’s ‘Golden Triangle’ of biotech innovation can compete on the world stage, AstraZeneca (LSE:…

AstraZenecaBoardroomBrilintaInterviewsPharmaceuticalUK

Merck KGaA eighth EPP spin-off to focus on infertility treatment

Merck KGaA eighth EPP spin-off to focus on infertility treatment

02-12-2013

USA-based EMD Serono, one of German drug and chemical group Merck KGaA’s biotechnology subsidiaries,…

BiotechnologyEMD SeronoMerck KGaAMerck SeronoMergers & AcquisitionsReproductiveResearchTocopheRx

Takeda names GSK executive as next chief operating officer

Takeda names GSK executive as next chief operating officer

29-11-2013

Japan’s largest drugmaker, Takeda Pharmaceutical, says that Christophe Weber has been approved at the…

BoardroomManagementPharmaceuticalTakeda Pharmaceuticals

Germany’s Merck invests in further research partnerships in Israel

Germany’s Merck invests in further research partnerships in Israel

26-11-2013

German pharma and chemicals firm Merck KGaA says it is increasingly counting on partnerships with Israeli…

BiotechnologyChanBioFinancialMerck KGaAMetabomedNeurologicalOncologyResearchRest of the World

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

20-11-2013

Privately-held Biopharma GmbH says it has signed an agreement with Merck Serono, the biopharma subsidiary…

Anti-Arthritics/RheumaticsBiopharm GmbHMerck KGaAMerck SeronoPharmaceuticalResearch

Immunologist Yong-Jun Liu named head of research at MedImmune

Immunologist Yong-Jun Liu named head of research at MedImmune

20-11-2013

US-based MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca…

BoardroomImmunologicalsMedImmuneNorth AmericaPharmaceuticalUSA

Jonathan Knowles named as executive chairman of the board of Immunocore and Adaptimmune

Jonathan Knowles named as executive chairman of the board of Immunocore and Adaptimmune

20-11-2013

UK-based biotech company Immunocore has appointed Jonathan Knowles as the new executive chairman of the…

AdaptimmuneBoardroomEuropeImmunocoreOncologyPharmaceuticalUK

Vectura appoints ex-AstraZeneca VP Bruno Angelici as non-executive chairman

Vectura appoints ex-AstraZeneca VP Bruno Angelici as non-executive chairman

20-11-2013

UK-based developer of inhaled therapies Vectura Group (LSE: VEC) has announced the appointment of Bruno…

BoardroomEuropeUKVectura

AmpliPhi Biosciences announces Baxter Phillips as VP of corporate strategy and business development

20-11-2013

US-headquartered biotech company AmpliPhi BioSciences (OTCBB: APHB) has appointed Baxter Phillips III…

AmpliPhi BioSciencesBoardroomNorth AmericaUSA

Affimed Therapeutics appoints Jens-Peter Marschner as chief medical officer

Affimed Therapeutics appoints Jens-Peter Marschner as chief medical officer

20-11-2013

German privately-owned biopharmaceutical company Affimed Therapeutics has appointed Jens-Peter Marschner…

Affimed TherapeuticsBoardroomEuropeMerck KGaA

Interview: Clinigen’s CEO Peter George on the company’s record growth

Interview: Clinigen’s CEO Peter George on the company’s record growth

15-11-2013

If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.

BoardroomClinigen GroupFoscavirInterviewsOncologyPharmaceuticalRare diseasesUK

74 to 98 of 186 results

Back to top